Oslo Cancer Cluster – Innovation Park – From cancer research ...
occinnovationpark.comInfo. Oslo Cancer Cluster Innovation Park opened in May 2015. The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area. Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.
Oslo Cancer Cluster - Home - Facebook
www.facebook.com › oslocancerOslo Cancer Cluster. Last week's good news in English! Novartis Norge supports the IMPRESS study with 6 of its cancer medicines to treat up to 100 patients. IMPRESS-Norway is a national clinical study in precision cancer medicine, which is testing off-label treatments on cancer patients based on molecular changes in the patient’s tumour.